Wang J, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR, Chen YC, Chang SC, 2018. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 46: 799–806.
Arias C et al., 2017. A prospective cohort multicenter study of molecular epidemiology and phylogenomics of Staphylococcus aureus bacteremia in nine Latin American countries. Antimicrob Agents Chemother 61: 1–13.
Bouillaut L, McBride S, Sorg J, 2011. Genetic manipulation of Clostridium difficile. Curr Protoc Microbiol 23: 1–7.
Zhang K, McClure JA, Elsayed S, Louie T, Conly JM, 2005. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 43: 5026–5033.
Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter M, Gauduchon V, Vandenesch F, Etienne J, 1999. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29: 1128–1132.
Clinical and Laboratory Standards Institute , 2019. Performance standards for antimicrobial susceptibility testing. Twenty Nineth Informational Supplement. M100-S29. Wayne, PA: CLSI.
World Health Organization , 2021. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2021. Available at: http://www.who.int/glass/resources/publications/early-implementation-report-2020/en/. Accessed May 29, 2022.
García C, Rijnders M, Bruggeman C, Samalvides F, Stobberingh EE, Jacobs J, 2012. Antimicrobial resistance and molecular typing of Staphylococcus aureus bloodstream isolates from hospitals in Peru. J Infect 65: 406–411.
Reyes J et al., 2009. Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America. Clin Infect Dis 49: 1861–1867.
Seas C et al., 2018. Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study. J Antimicrob Chemother 73: 212–222.
Yaw LK, Robinson JO, Ho KM, 2014. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Lancet Infect Dis 14: 967–975.
Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y, 2003. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36: 53–59.
Joo EJ, Park DA, Kang CI, Chung DR, Song JH, Lee SM, Peck KR, 2019. Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis. Korean J Intern Med (Korean Assoc Intern Med) 34: 1347–1362.
Inagaki K, Lucar J, Blackshear C, Hobbs C, 2019. Methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia: nationwide estimates of 30-day readmission, in-hospital mortality, length of stay, and cost in the United States. Clin Infect Dis 69: 2112–2118.
Austin ED, Sullivan SS, Macesic N, Mehta M, Miko BA, Nematollahi S, Shi Q, Lowy F, Uhlemann AC, 2020. Reduced mortality of Staphylococcus aureus bacteremia in a retrospective cohort study of 2139 patients: 2007–2015. Clin Infect Dis 70: 1666–1674.
Schwalb A, Cachay R, de la Flor A, García C, Seas C, 2020. Adherence to standards of care and mortality in the management of Staphylococcus aureus bacteraemia in Peru: a prospective cohort study. Int J Infect Dis 96: 601–606.
Krapp F et al., 2021. Underutilization and quality gaps in blood culture processing in public hospitals of Peru. Am J Trop Med Hyg 106: 432–440.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 3826 | 2379 | 89 |
Full Text Views | 211 | 52 | 14 |
PDF Downloads | 101 | 36 | 0 |
There is a knowledge gap in the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) causing bloodstream infections (BSIs) in Peru. Through a surveillance study in 13 hospitals of 10 Peruvian regions (2017–2019), we assessed the proportion of MRSA among S. aureus BSIs as well as the molecular typing of the isolates. A total of 166 S. aureus isolates were collected, and 36.1% of them were MRSA. Of note, MRSA isolates with phenotypic and genetic characteristics of the hospital-associated Chilean-Cordobes clone (multidrug-resistant SCCmec I, non–Panton-Valentine leukocidin [PVL] producers) were most commonly found (70%), five isolates with genetic characteristics of community-associated MRSA (CA-MRSA)—SCCmec IV, PVL-producer—(8.3%) were seen in three separate regions. These results demonstrate that hospital-associated MRSA is the most frequent MRSA found in patients with BSIs in Peru. They also show the emergence of S. aureus with genetic characteristics of CA-MRSA. Further studies are needed to evaluate the extension of CA-MRSA dissemination in Peru.
Financial support: This work was funded by the
Authors’ addresses: Coralith García, Instituto de Medicina Tropical Alexander von Humboldt and Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru and Departamento de Enfermedades Infecciosas, Tropicales y Dermatológicas, Hospital Cayetano Heredia, Lima, Peru, E-mail: coralith.garcia@upch.pe. Noemi Hinostroza, Lizeth Astocondor and Saul Alejos, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru, E-mails: noemi.hinostroza.s@gmail.com, astocondor.lizeth@gmail.com and savaf@hotmail.com. Valeria Gordillo and Maria L Inchaustegui, Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru, E-mails: valeria.gordillo@upch.pe and maria.inchaustegui@upch.pe. Omayra Chincha, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru and Departamento de Enfermedades Infecciosas, Tropicales y Dermatológicas, Hospital Cayetano Heredia, Lima, Peru, E-mail: omychin@gmail.com. Marco Olivera Servicio de Infectología y Medicina Tropical, Hospital María Auxiliadora, Lima Peru, E-mail: marco_fmh@hotmail.com. Digna Bojórquez-Fernández, Departamento de Patología Clínica y Anatomía Patológica, Hospital María, LiAuxiliadorama Peru, E-mail: dina_849@hotmail.com. Fátima Concha-Velasco, Departamento de Medicina, Hospital Antonio Lorena, Cusco, Peru and Escuela Profesional de Medicina Humana, Universidad Nacional San Antonio de Abad del Cusco, Cusco, Peru, E-mail: fatima.concha.v@upch.pe. Nancy Vásquez, Departamento de Apoyo al Diagnóstico, Hospital Antonio Lorena, Cusco, Peru, E-mail: nancyvalu@hotmail.com. Alex Castaneda-Sabogal, Departamento de Medicina, Hospital Base Víctor Lazarte Echegaray de EsSalud, La Libertad, Peru, and Facultad de Medicina Humana, Universidad Privada Antenor Orrego, Trujillo, Peru, E-mail: alex.castaneda.s@upch.pe. Pedro Sullón, Departamento de Especialidades Médicas, Hospital Hipólito Unanue, Lima, Peru, E-mail: pedro_sullon1@yahoo.es. Víctor Fernández, Departamento de Medicina, Hospital Belén de Trujillo, La Libertad, Peru, E-mail: solhuanchac@hotmail.com. Miguel Villegas-Chiroque, Departamento de Áreas Clínicas, Hospital Regional Lambayeque, Lambayeque, Peru, E-mail: mivichi2003@hotmail.com. Enrique López, Departamento de Medicina, Hospital Regional de Loreto Felipe Santiago Arriola Iglesias, Loreto, Peru, E-mail: enriquelopez62879gmail.com. Miguel Hueda-Zavaleta, Faculty of Health Sciences, Universidad Privada de Tacna, Tacna, Peru, and Departamento de Medicina, Hospital III Daniel Alcides Carrión–EsSalud Tacna, Tacna, Peru, E-mail: miguelhueda90@gmail.com. Ana Vidaurre, Departamento de Medicina, Hospital III EsSalud Chimbote, Ancash, Peru, E-mail: ana.vidaurre@essalud.gob.pe. César Bocángel, Departamento de Medicina, Hospital Goyeneche de Arequipa, Arequipa, Peru, E-mail: cesdaboc@gmail.com. Evelyn Barco, Departamento de Patología Clínica, Hospital Regional II-2 José Alfredo Mendoza Olavarría, Tumbes, Peru, E-mail: evelynbarco@gmail.com. Eduardo Paricahua, Departamento de Medicina, Hospital Santa Rosa de Puerto Maldonado, Madre de Dios, Peru, E-mail: epaper4000@gmail.com. Marcus Zervos, Infectious Disease Division, Henry Ford Health System, Detroit, MI, E-mail: mzervos1@hfhs.org. Jan Jacobs, Institute of Tropical Medicine, Antwerp, Belgium, and Department of Microbiology, Immunology and Transplantation, KU Leuven, Belgium, E-mail: jjacobs@itg.be. Fiorella Krapp, Instituto de Medicina Tropical Alexander von Humboldt and Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru, and Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium, E-mail: fiorella.krapp@upch.pe.
Wang J, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR, Chen YC, Chang SC, 2018. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 46: 799–806.
Arias C et al., 2017. A prospective cohort multicenter study of molecular epidemiology and phylogenomics of Staphylococcus aureus bacteremia in nine Latin American countries. Antimicrob Agents Chemother 61: 1–13.
Bouillaut L, McBride S, Sorg J, 2011. Genetic manipulation of Clostridium difficile. Curr Protoc Microbiol 23: 1–7.
Zhang K, McClure JA, Elsayed S, Louie T, Conly JM, 2005. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 43: 5026–5033.
Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter M, Gauduchon V, Vandenesch F, Etienne J, 1999. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29: 1128–1132.
Clinical and Laboratory Standards Institute , 2019. Performance standards for antimicrobial susceptibility testing. Twenty Nineth Informational Supplement. M100-S29. Wayne, PA: CLSI.
World Health Organization , 2021. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2021. Available at: http://www.who.int/glass/resources/publications/early-implementation-report-2020/en/. Accessed May 29, 2022.
García C, Rijnders M, Bruggeman C, Samalvides F, Stobberingh EE, Jacobs J, 2012. Antimicrobial resistance and molecular typing of Staphylococcus aureus bloodstream isolates from hospitals in Peru. J Infect 65: 406–411.
Reyes J et al., 2009. Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America. Clin Infect Dis 49: 1861–1867.
Seas C et al., 2018. Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study. J Antimicrob Chemother 73: 212–222.
Yaw LK, Robinson JO, Ho KM, 2014. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Lancet Infect Dis 14: 967–975.
Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y, 2003. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36: 53–59.
Joo EJ, Park DA, Kang CI, Chung DR, Song JH, Lee SM, Peck KR, 2019. Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis. Korean J Intern Med (Korean Assoc Intern Med) 34: 1347–1362.
Inagaki K, Lucar J, Blackshear C, Hobbs C, 2019. Methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia: nationwide estimates of 30-day readmission, in-hospital mortality, length of stay, and cost in the United States. Clin Infect Dis 69: 2112–2118.
Austin ED, Sullivan SS, Macesic N, Mehta M, Miko BA, Nematollahi S, Shi Q, Lowy F, Uhlemann AC, 2020. Reduced mortality of Staphylococcus aureus bacteremia in a retrospective cohort study of 2139 patients: 2007–2015. Clin Infect Dis 70: 1666–1674.
Schwalb A, Cachay R, de la Flor A, García C, Seas C, 2020. Adherence to standards of care and mortality in the management of Staphylococcus aureus bacteraemia in Peru: a prospective cohort study. Int J Infect Dis 96: 601–606.
Krapp F et al., 2021. Underutilization and quality gaps in blood culture processing in public hospitals of Peru. Am J Trop Med Hyg 106: 432–440.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 3826 | 2379 | 89 |
Full Text Views | 211 | 52 | 14 |
PDF Downloads | 101 | 36 | 0 |